Position in GILD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,015,621,242
+$58,197,940 QoQ
Shares Held
7,287,230
-6.6% QoQ
Ownership
0.587%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 80%
None 20%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026AMERIPRISE FINANCIAL INC holds $15,736,449,872 across 16 Drug Manufacturers - General names. GILD ranks #7 (6.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
13,779,406 | $3,368,238,000 | |
| 2 | LLY |
ELI LILLY & Co
|
2,984,392 | $2,744,954,225 | |
| 3 | ABBV |
AbbVie Inc.
|
11,068,310 | $2,407,246,738 | |
| 4 | MRK |
Merck & Co., Inc.
|
16,262,708 | $1,956,241,142 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
26,470,718 | $1,605,449,043 | |
| 6 | AZN |
Astrazeneca PLC
|
5,747,087 | $1,133,440,495 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
7,287,230 | $1,015,621,242 | |
| 8 | AMGN |
Amgen Inc
|
2,023,367 | $711,921,677 |
All Filings in GILD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,015,621,242 | 7,287,230 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $957,423,302 | 7,800,418 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $793,472,955 | 7,148,405 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $748,195,437 | 6,748,403 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $151,963,552 | 1,356,212 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $122,903,177 | 1,330,553 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $158,608,845 | 1,891,804 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $136,757,222 | 1,993,255 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $119,058,864 | 1,625,377 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $128,735,500 | 1,589,131 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $127,681,495 | 1,703,783 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $122,432,937 | 1,588,594 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $139,287,959 | 1,678,775 | Shares | Defined | 2023-05-22 | |
| 2022-12-31 | $126,588,828 | 1,474,535 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $99,438,909 | 1,611,913 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $102,873,717 | 1,664,354 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $109,230,633 | 1,837,353 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $104,458,342 | 1,438,622 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $83,796,038 | 1,199,657 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $260,776,605 | 3,787,055 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $254,933,032 | 3,944,500 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $266,658,989 | 4,577,051 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $292,970,765 | 4,636,347 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $345,802,904 | 4,494,449 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $465,133,990 | 6,221,696 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||